The team behind TOXsIgN has invested considerable time, resources, and effort into collecting, curating, processing, developing, and maintaining this web resource.
×
TSP48873-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures after exposure to salirasib TSA204918-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to salirasib TSA204952-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to salirasib TSA204979-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to salirasib TSA205024-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line YAPC after exposure to salirasib TSA204775-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A375 after exposure to salirasib TSA204817-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to salirasib TSA204870-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HELA after exposure to salirasib TSA217297-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A549 after exposure to salirasib TSA217351-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HEK293 after exposure to salirasib TSA217405-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line JURKAT after exposure to salirasib TSA217460-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF10A after exposure to salirasib TSA217515-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MDAMB231 after exposure to salirasib TSA217565-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line THP1 after exposure to salirasib TSF446785-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to salirasib 3.33 µM for 24.0 h 1 subfactor(s) TSF446787-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to salirasib 0.37 µM for 24.0 h 1 subfactor(s) TSF446784-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to salirasib 10.0 µM for 24.0 h 1 subfactor(s) TSF446786-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to salirasib 1.11 µM for 24.0 h 1 subfactor(s) TSF446789-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to salirasib 0.04 µM for 24.0 h 1 subfactor(s) TSF446788-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to salirasib 0.125 µM for 24.0 h 1 subfactor(s) TSF549682-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to salirasib 2.22 µM for 24.0 h 1 subfactor(s) TSF549683-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to salirasib 0.74 µM for 24.0 h 1 subfactor(s) TSF549684-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to salirasib 0.25 µM for 24.0 h 1 subfactor(s) TSF549685-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to salirasib 0.08 µM for 24.0 h 1 subfactor(s) TSF549686-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to salirasib 0.03 µM for 24.0 h 1 subfactor(s) TSF549687-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to salirasib 0.01 µM for 24.0 h 1 subfactor(s) TSF447074-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to salirasib 3.33 µM for 24.0 h 1 subfactor(s) TSF447075-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to salirasib 1.11 µM for 24.0 h 1 subfactor(s) TSF447073-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to salirasib 10.0 µM for 24.0 h 1 subfactor(s) TSF447076-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to salirasib 0.37 µM for 24.0 h 1 subfactor(s) TSF447077-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to salirasib 0.125 µM for 24.0 h 1 subfactor(s) TSF447078-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to salirasib 0.04 µM for 24.0 h 1 subfactor(s) TSF550687-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to salirasib 2.22 µM for 24.0 h 1 subfactor(s) TSF550688-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to salirasib 0.74 µM for 24.0 h 1 subfactor(s) TSF550689-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to salirasib 0.25 µM for 24.0 h 1 subfactor(s) TSF550690-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to salirasib 0.08 µM for 24.0 h 1 subfactor(s) TSF550691-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to salirasib 0.03 µM for 24.0 h 1 subfactor(s) TSF550692-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to salirasib 0.01 µM for 24.0 h 1 subfactor(s) TSF447341-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to salirasib 10.0 µM for 24.0 h 1 subfactor(s) TSF447342-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to salirasib 3.33 µM for 24.0 h 1 subfactor(s) TSF447343-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to salirasib 1.11 µM for 24.0 h 1 subfactor(s) TSF447344-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to salirasib 0.37 µM for 24.0 h 1 subfactor(s) TSF447345-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to salirasib 0.125 µM for 24.0 h 1 subfactor(s) TSF447346-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to salirasib 0.04 µM for 24.0 h 1 subfactor(s) TSF551360-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to salirasib 0.08 µM for 24.0 h 1 subfactor(s) TSF551361-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to salirasib 0.03 µM for 24.0 h 1 subfactor(s) TSF551357-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to salirasib 2.22 µM for 24.0 h 1 subfactor(s) TSF551358-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to salirasib 0.74 µM for 24.0 h 1 subfactor(s) TSF551359-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to salirasib 0.25 µM for 24.0 h 1 subfactor(s) TSF551362-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to salirasib 0.01 µM for 24.0 h 1 subfactor(s) TSF447652-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line YAPC after exposure to salirasib 10.0 µM for 24.0 h 1 subfactor(s) TSF447653-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line YAPC after exposure to salirasib 3.33 µM for 24.0 h 1 subfactor(s) TSF447654-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line YAPC after exposure to salirasib 1.11 µM for 24.0 h 1 subfactor(s) TSF447655-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line YAPC after exposure to salirasib 0.37 µM for 24.0 h 1 subfactor(s) TSF447656-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line YAPC after exposure to salirasib 0.125 µM for 24.0 h 1 subfactor(s) TSF447657-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line YAPC after exposure to salirasib 0.04 µM for 24.0 h 1 subfactor(s) TSF552025-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line YAPC after exposure to salirasib 0.25 µM for 24.0 h 1 subfactor(s) TSF552023-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line YAPC after exposure to salirasib 2.22 µM for 24.0 h 1 subfactor(s) TSF552026-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line YAPC after exposure to salirasib 0.08 µM for 24.0 h 1 subfactor(s) TSF552024-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line YAPC after exposure to salirasib 0.74 µM for 24.0 h 1 subfactor(s) TSF552027-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line YAPC after exposure to salirasib 0.03 µM for 24.0 h 1 subfactor(s) TSF552028-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line YAPC after exposure to salirasib 0.01 µM for 24.0 h 1 subfactor(s) TSF445865-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A375 after exposure to salirasib 10.0 µM for 24.0 h 1 subfactor(s) TSF445866-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A375 after exposure to salirasib 3.33 µM for 24.0 h 1 subfactor(s) TSF445868-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A375 after exposure to salirasib 0.37 µM for 24.0 h 1 subfactor(s) TSF445867-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A375 after exposure to salirasib 1.11 µM for 24.0 h 1 subfactor(s) TSF445869-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A375 after exposure to salirasib 0.125 µM for 24.0 h 1 subfactor(s) TSF445870-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A375 after exposure to salirasib 0.04 µM for 24.0 h 1 subfactor(s) TSF548022-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A375 after exposure to salirasib 0.74 µM for 24.0 h 1 subfactor(s) TSF548021-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A375 after exposure to salirasib 2.22 µM for 24.0 h 1 subfactor(s) TSF548024-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A375 after exposure to salirasib 0.08 µM for 24.0 h 1 subfactor(s) TSF548023-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A375 after exposure to salirasib 0.25 µM for 24.0 h 1 subfactor(s) TSF548025-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A375 after exposure to salirasib 0.03 µM for 24.0 h 1 subfactor(s) TSF548026-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A375 after exposure to salirasib 0.01 µM for 24.0 h 1 subfactor(s) TSF446153-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to salirasib 10.0 µM for 24.0 h 1 subfactor(s) TSF446154-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to salirasib 3.33 µM for 24.0 h 1 subfactor(s) TSF446155-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to salirasib 1.11 µM for 24.0 h 1 subfactor(s) TSF446156-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to salirasib 0.37 µM for 24.0 h 1 subfactor(s) TSF446157-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to salirasib 0.125 µM for 24.0 h 1 subfactor(s) TSF446158-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to salirasib 0.04 µM for 24.0 h 1 subfactor(s) TSF548676-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to salirasib 0.74 µM for 24.0 h 1 subfactor(s) TSF548675-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to salirasib 2.22 µM for 24.0 h 1 subfactor(s) TSF548677-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to salirasib 0.25 µM for 24.0 h 1 subfactor(s) TSF548680-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to salirasib 0.01 µM for 24.0 h 1 subfactor(s) TSF548678-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to salirasib 0.08 µM for 24.0 h 1 subfactor(s) TSF548679-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to salirasib 0.03 µM for 24.0 h 1 subfactor(s) TSF446478-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HELA after exposure to salirasib 3.33 µM for 24.0 h 1 subfactor(s) TSF446477-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HELA after exposure to salirasib 10.0 µM for 24.0 h 1 subfactor(s) TSF446479-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HELA after exposure to salirasib 1.11 µM for 24.0 h 1 subfactor(s) TSF446480-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HELA after exposure to salirasib 0.37 µM for 24.0 h 1 subfactor(s) TSF446481-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HELA after exposure to salirasib 0.125 µM for 24.0 h 1 subfactor(s) TSF446482-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HELA after exposure to salirasib 0.04 µM for 24.0 h 1 subfactor(s) TSF549347-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HELA after exposure to salirasib 2.22 µM for 24.0 h 1 subfactor(s) TSF549348-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HELA after exposure to salirasib 0.74 µM for 24.0 h 1 subfactor(s) TSF549349-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HELA after exposure to salirasib 0.25 µM for 24.0 h 1 subfactor(s) TSF549350-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HELA after exposure to salirasib 0.08 µM for 24.0 h 1 subfactor(s) TSF549351-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HELA after exposure to salirasib 0.03 µM for 24.0 h 1 subfactor(s) TSF549352-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HELA after exposure to salirasib 0.01 µM for 24.0 h 1 subfactor(s) TSF548348-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A549 after exposure to salirasib 2.22 µM for 24.0 h 1 subfactor(s) TSF548351-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A549 after exposure to salirasib 0.08 µM for 24.0 h 1 subfactor(s) TSF548349-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A549 after exposure to salirasib 0.74 µM for 24.0 h 1 subfactor(s) TSF548350-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A549 after exposure to salirasib 0.25 µM for 24.0 h 1 subfactor(s) TSF548353-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A549 after exposure to salirasib 0.01 µM for 24.0 h 1 subfactor(s) TSF548352-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A549 after exposure to salirasib 0.03 µM for 24.0 h 1 subfactor(s) TSF549011-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HEK293 after exposure to salirasib 2.22 µM for 24.0 h 1 subfactor(s) TSF549012-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HEK293 after exposure to salirasib 0.74 µM for 24.0 h 1 subfactor(s) TSF549013-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HEK293 after exposure to salirasib 0.25 µM for 24.0 h 1 subfactor(s) TSF549014-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HEK293 after exposure to salirasib 0.08 µM for 24.0 h 1 subfactor(s) TSF549015-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HEK293 after exposure to salirasib 0.03 µM for 24.0 h 1 subfactor(s) TSF549016-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HEK293 after exposure to salirasib 0.01 µM for 24.0 h 1 subfactor(s) TSF550019-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line JURKAT after exposure to salirasib 0.74 µM for 24.0 h 1 subfactor(s) TSF550018-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line JURKAT after exposure to salirasib 2.22 µM for 24.0 h 1 subfactor(s) TSF550022-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line JURKAT after exposure to salirasib 0.03 µM for 24.0 h 1 subfactor(s) TSF550020-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line JURKAT after exposure to salirasib 0.25 µM for 24.0 h 1 subfactor(s) TSF550021-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line JURKAT after exposure to salirasib 0.08 µM for 24.0 h 1 subfactor(s) TSF550023-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line JURKAT after exposure to salirasib 0.01 µM for 24.0 h 1 subfactor(s) TSF550355-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF10A after exposure to salirasib 0.74 µM for 24.0 h 1 subfactor(s) TSF550354-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF10A after exposure to salirasib 2.22 µM for 24.0 h 1 subfactor(s) TSF550356-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF10A after exposure to salirasib 0.25 µM for 24.0 h 1 subfactor(s) TSF550357-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF10A after exposure to salirasib 0.08 µM for 24.0 h 1 subfactor(s) TSF550358-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF10A after exposure to salirasib 0.03 µM for 24.0 h 1 subfactor(s) TSF550359-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF10A after exposure to salirasib 0.01 µM for 24.0 h 1 subfactor(s) TSF551027-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MDAMB231 after exposure to salirasib 0.01 µM for 24.0 h 1 subfactor(s) TSF551022-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MDAMB231 after exposure to salirasib 2.22 µM for 24.0 h 1 subfactor(s) TSF551023-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MDAMB231 after exposure to salirasib 0.74 µM for 24.0 h 1 subfactor(s) TSF551024-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MDAMB231 after exposure to salirasib 0.25 µM for 24.0 h 1 subfactor(s) TSF551025-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MDAMB231 after exposure to salirasib 0.08 µM for 24.0 h 1 subfactor(s) TSF551026-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MDAMB231 after exposure to salirasib 0.03 µM for 24.0 h 1 subfactor(s) TSF551691-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line THP1 after exposure to salirasib 0.74 µM for 24.0 h 1 subfactor(s) TSF551692-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line THP1 after exposure to salirasib 0.25 µM for 24.0 h 1 subfactor(s) TSF551690-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line THP1 after exposure to salirasib 2.22 µM for 24.0 h 1 subfactor(s) TSF551693-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line THP1 after exposure to salirasib 0.08 µM for 24.0 h 1 subfactor(s) TSF551694-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line THP1 after exposure to salirasib 0.03 µM for 24.0 h 1 subfactor(s) TSF551695-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line THP1 after exposure to salirasib 0.01 µM for 24.0 h 1 subfactor(s) TSS446794-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to salirasib 3.33 µM for 24.0 h TSS446796-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to salirasib 0.37 µM for 24.0 h TSS446793-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to salirasib 10.0 µM for 24.0 h TSS446795-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to salirasib 1.11 µM for 24.0 h TSS446798-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to salirasib 0.04 µM for 24.0 h TSS446797-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to salirasib 0.125 µM for 24.0 h TSS549692-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to salirasib 2.22 µM for 24.0 h TSS549693-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to salirasib 0.74 µM for 24.0 h TSS549694-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to salirasib 0.25 µM for 24.0 h TSS549695-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to salirasib 0.08 µM for 24.0 h TSS549696-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to salirasib 0.03 µM for 24.0 h TSS549697-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to salirasib 0.01 µM for 24.0 h TSS447083-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to salirasib 3.33 µM for 24.0 h TSS447084-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to salirasib 1.11 µM for 24.0 h TSS447082-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to salirasib 10.0 µM for 24.0 h TSS447085-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to salirasib 0.37 µM for 24.0 h TSS447086-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to salirasib 0.125 µM for 24.0 h TSS447087-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to salirasib 0.04 µM for 24.0 h TSS550697-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to salirasib 2.22 µM for 24.0 h TSS550698-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to salirasib 0.74 µM for 24.0 h TSS550699-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to salirasib 0.25 µM for 24.0 h TSS550700-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to salirasib 0.08 µM for 24.0 h TSS550701-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to salirasib 0.03 µM for 24.0 h TSS550702-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to salirasib 0.01 µM for 24.0 h TSS447350-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to salirasib 10.0 µM for 24.0 h TSS447351-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to salirasib 3.33 µM for 24.0 h TSS447352-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to salirasib 1.11 µM for 24.0 h TSS447353-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to salirasib 0.37 µM for 24.0 h TSS447354-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to salirasib 0.125 µM for 24.0 h TSS447355-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to salirasib 0.04 µM for 24.0 h TSS551370-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to salirasib 0.08 µM for 24.0 h TSS551371-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to salirasib 0.03 µM for 24.0 h TSS551367-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to salirasib 2.22 µM for 24.0 h TSS551368-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to salirasib 0.74 µM for 24.0 h TSS551369-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to salirasib 0.25 µM for 24.0 h TSS551372-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to salirasib 0.01 µM for 24.0 h TSS447661-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line YAPC after exposure to salirasib 10.0 µM for 24.0 h TSS447662-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line YAPC after exposure to salirasib 3.33 µM for 24.0 h TSS447663-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line YAPC after exposure to salirasib 1.11 µM for 24.0 h TSS447664-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line YAPC after exposure to salirasib 0.37 µM for 24.0 h TSS447665-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line YAPC after exposure to salirasib 0.125 µM for 24.0 h TSS447666-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line YAPC after exposure to salirasib 0.04 µM for 24.0 h TSS552035-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line YAPC after exposure to salirasib 0.25 µM for 24.0 h TSS552033-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line YAPC after exposure to salirasib 2.22 µM for 24.0 h TSS552036-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line YAPC after exposure to salirasib 0.08 µM for 24.0 h TSS552034-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line YAPC after exposure to salirasib 0.74 µM for 24.0 h TSS552037-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line YAPC after exposure to salirasib 0.03 µM for 24.0 h TSS552038-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line YAPC after exposure to salirasib 0.01 µM for 24.0 h TSS445874-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A375 after exposure to salirasib 10.0 µM for 24.0 h TSS445875-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A375 after exposure to salirasib 3.33 µM for 24.0 h TSS445877-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A375 after exposure to salirasib 0.37 µM for 24.0 h TSS445876-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A375 after exposure to salirasib 1.11 µM for 24.0 h TSS445878-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A375 after exposure to salirasib 0.125 µM for 24.0 h TSS445879-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A375 after exposure to salirasib 0.04 µM for 24.0 h TSS548032-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A375 after exposure to salirasib 0.74 µM for 24.0 h TSS548031-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A375 after exposure to salirasib 2.22 µM for 24.0 h TSS548034-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A375 after exposure to salirasib 0.08 µM for 24.0 h TSS548033-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A375 after exposure to salirasib 0.25 µM for 24.0 h TSS548035-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A375 after exposure to salirasib 0.03 µM for 24.0 h TSS548036-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A375 after exposure to salirasib 0.01 µM for 24.0 h TSS446162-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to salirasib 10.0 µM for 24.0 h TSS446163-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to salirasib 3.33 µM for 24.0 h TSS446164-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to salirasib 1.11 µM for 24.0 h TSS446165-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to salirasib 0.37 µM for 24.0 h TSS446166-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to salirasib 0.125 µM for 24.0 h TSS446167-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to salirasib 0.04 µM for 24.0 h TSS548686-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to salirasib 0.74 µM for 24.0 h TSS548685-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to salirasib 2.22 µM for 24.0 h TSS548687-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to salirasib 0.25 µM for 24.0 h TSS548690-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to salirasib 0.01 µM for 24.0 h TSS548688-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to salirasib 0.08 µM for 24.0 h TSS548689-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to salirasib 0.03 µM for 24.0 h TSS446487-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HELA after exposure to salirasib 3.33 µM for 24.0 h TSS446486-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HELA after exposure to salirasib 10.0 µM for 24.0 h TSS446488-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HELA after exposure to salirasib 1.11 µM for 24.0 h TSS446489-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HELA after exposure to salirasib 0.37 µM for 24.0 h TSS446490-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HELA after exposure to salirasib 0.125 µM for 24.0 h TSS446491-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HELA after exposure to salirasib 0.04 µM for 24.0 h TSS549357-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HELA after exposure to salirasib 2.22 µM for 24.0 h TSS549358-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HELA after exposure to salirasib 0.74 µM for 24.0 h TSS549359-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HELA after exposure to salirasib 0.25 µM for 24.0 h TSS549360-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HELA after exposure to salirasib 0.08 µM for 24.0 h TSS549361-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HELA after exposure to salirasib 0.03 µM for 24.0 h TSS549362-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HELA after exposure to salirasib 0.01 µM for 24.0 h TSS548358-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A549 after exposure to salirasib 2.22 µM for 24.0 h TSS548361-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A549 after exposure to salirasib 0.08 µM for 24.0 h TSS548359-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A549 after exposure to salirasib 0.74 µM for 24.0 h TSS548360-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A549 after exposure to salirasib 0.25 µM for 24.0 h TSS548363-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A549 after exposure to salirasib 0.01 µM for 24.0 h TSS548362-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A549 after exposure to salirasib 0.03 µM for 24.0 h TSS549021-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HEK293 after exposure to salirasib 2.22 µM for 24.0 h TSS549022-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HEK293 after exposure to salirasib 0.74 µM for 24.0 h TSS549023-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HEK293 after exposure to salirasib 0.25 µM for 24.0 h TSS549024-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HEK293 after exposure to salirasib 0.08 µM for 24.0 h TSS549025-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HEK293 after exposure to salirasib 0.03 µM for 24.0 h TSS549026-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HEK293 after exposure to salirasib 0.01 µM for 24.0 h TSS550029-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line JURKAT after exposure to salirasib 0.74 µM for 24.0 h TSS550028-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line JURKAT after exposure to salirasib 2.22 µM for 24.0 h TSS550032-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line JURKAT after exposure to salirasib 0.03 µM for 24.0 h TSS550030-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line JURKAT after exposure to salirasib 0.25 µM for 24.0 h TSS550031-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line JURKAT after exposure to salirasib 0.08 µM for 24.0 h TSS550033-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line JURKAT after exposure to salirasib 0.01 µM for 24.0 h TSS550365-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF10A after exposure to salirasib 0.74 µM for 24.0 h TSS550364-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF10A after exposure to salirasib 2.22 µM for 24.0 h TSS550366-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF10A after exposure to salirasib 0.25 µM for 24.0 h TSS550367-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF10A after exposure to salirasib 0.08 µM for 24.0 h TSS550368-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF10A after exposure to salirasib 0.03 µM for 24.0 h TSS550369-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF10A after exposure to salirasib 0.01 µM for 24.0 h TSS551037-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MDAMB231 after exposure to salirasib 0.01 µM for 24.0 h TSS551032-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MDAMB231 after exposure to salirasib 2.22 µM for 24.0 h TSS551033-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MDAMB231 after exposure to salirasib 0.74 µM for 24.0 h TSS551034-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MDAMB231 after exposure to salirasib 0.25 µM for 24.0 h TSS551035-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MDAMB231 after exposure to salirasib 0.08 µM for 24.0 h TSS551036-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MDAMB231 after exposure to salirasib 0.03 µM for 24.0 h TSS551701-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line THP1 after exposure to salirasib 0.74 µM for 24.0 h TSS551702-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line THP1 after exposure to salirasib 0.25 µM for 24.0 h TSS551700-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line THP1 after exposure to salirasib 2.22 µM for 24.0 h TSS551703-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line THP1 after exposure to salirasib 0.08 µM for 24.0 h TSS551704-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line THP1 after exposure to salirasib 0.03 µM for 24.0 h TSS551705-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line THP1 after exposure to salirasib 0.01 µM for 24.0 h
TSP48873 - CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures after exposure to salirasib
Public
https://clue.io/data/CMap2020#LINCS2020
Experimental design
No experimental design provided
Results
No results provided